Neurostimulation in neurogenic patients.
Denervation
Electric Stimulation
Electric Stimulation Therapy
/ adverse effects
Humans
Implantable Neurostimulators
Lower Urinary Tract Symptoms
/ physiopathology
Rhizotomy
Sacrococcygeal Region
Spinal Nerve Roots
/ physiopathology
Tibial Nerve
Urinary Bladder
/ innervation
Urinary Bladder, Neurogenic
/ etiology
Journal
Current opinion in urology
ISSN: 1473-6586
Titre abrégé: Curr Opin Urol
Pays: United States
ID NLM: 9200621
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
pubmed:
20
5
2020
medline:
18
12
2020
entrez:
20
5
2020
Statut:
ppublish
Résumé
To provide an overview of available electrical stimulation devices in neurogenic patients with lower urinary tract disease. It is advocated to do more studies in neurogenic patients as results seem promising and useful but most studies did not include neurogenic patients or neurogenic patients were not analyzed or reported separately. Most studies included a small heterogenous neurogenic group with multiple pathophysiologic origin focusing on effect of a treatment instead of results of a treatment in a specific neurogenic group. Neuromodulation or stimulation has the advantage that it acts on different organs, like bladder and bowel, so can treat neurogenic patients, who mostly suffer from multiple organ failure. Brindley procedure, sacral neuromodulation (SNM) and posterior tibial nerve stimulation (PTNS) are available for a while already. The Brindley procedure (including sacral anterior root stimulation in combination with a rhizotomy of posterior sacral roots) is developed for selected spinal cord injury patient with a complete spinal injury, and has shown results for many years in neurogenic patients. An alternative to the rhizotomy is not established yet. SNM and PTNS are other modalities that are used in nonneurogenic patients, but are not yet indicated and much studied in neurogenic patients.
Identifiants
pubmed: 32427629
doi: 10.1097/MOU.0000000000000773
pii: 00042307-202007000-00008
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
507-512Commentaires et corrections
Type : CommentIn
Références
Fowler CJ, Griffiths D, de Groat WC. The neural control of micturition. Nat Rev Neurosci 2008; 9:453–466.
Castaño-Botero JC, Ospina-Galeano IA, Gómez-Illanes R, et al. Extradural Implantation of sacral anterior root stimulator in spinal cord injury patients. Neurourol Urodyn 2016; 35:970–974.
Sauerwein D. Surgical treatment of spastic bladder paralysis in paraplegic patients. Sacral deafferentation with implantation of a sacral anterior root stimulator. Urologe A 1990; 29:196–203.
Hohenfellner M, Pannek J, Botel U, et al. Sacral bladder denervation for treatment of detrusor hyperreflexia and autonomic dysreflexia. Urology 2001; 58:28–32.
Van Kerrebroeck PE, Koldewijn EL, Rosier PF, et al. Results of the treatment of neurogenic bladder dysfunction in spinal cord injury by sacral posterior root rhizotomy and anterior sacral root stimulation. J Urol 1996; 155:1378–1381.
Martens FM, Heesakkers JP. Clinical results of a brindley procedure: sacral anterior root stimulation in combination with a rhizotomy of the dorsal roots. Adv Urol 2011; 2011:709708.
Rasmussen MM, Kutzenberger J, Krogh K, et al. Sacral anterior root stimulation improves bowel function in individuals with spinal cord injury. Spinal Cord 2015; 53:297–301.
Martens FM, den Hollander PP, Snoek GJ, et al. Quality of life in complete spinal cord injury patients with a Brindley bladder stimulator compared to a matched control group. Neurourol Urodyn 2011; 30:551–555.
Morliere C, Verpillot E, Donon L, et al. A cost-utility analysis of sacral anterior root stimulation (SARS) compared with medical treatment in patients with complete spinal cord injury with a neurogenic bladder. Spine J 2015; 15:2472–2483.
Krebs J, Wollner J, Grasmucke D, et al. Long-term course of sacral anterior root stimulation in spinal cord injured individuals: the fate of the detrusor. Neurourol Urodyn 2017; 36:1596–1600.
Martens FM, Heesakkers JP, Rijkhoff NJ. Surgical access for electrical stimulation of the pudendal and dorsal genital nerves in the overactive bladder: a review. J Urol 2011; 186:798–804.
Schurch B, Reilly I, Reitz A, et al. Electrophysiological recordings during the peripheral nerve evaluation (PNE) test in complete spinal cord injury patients. World J Urol 2003; 20:319–322.
Sievert KD, Amend B, Gakis G, et al. Early sacral neuromodulation prevents urinary incontinence after complete spinal cord injury. Ann Neurol 2010; 67:74–84.
Keller EE, Patras I, Hutu I, et al. Early sacral neuromodulation ameliorates urinary bladder function and structure in complete spinal cord injury minipigs. Neurourol Urodyn 2019; 39:586–593.
Lee YJ, Yoon CY, Lee MS, et al. Effect of early sacral neuromodulation on bladder function in a rat model of incomplete spinal cord injury due to focal contusion. Neuromodulation 2019; 22:697–702.
Redshaw JD, Lenherr SM, Elliott SP, et al. Neurogenic Bladder Research Group (NBRG.org). Protocol for a randomized clinical trial investigating early sacral nerve stimulation as an adjunct to standard neurogenic bladder management following acute spinal cord injury. BMC Urol 2018; 18:72.
Hohenfellner M, Humke J, Hampel C, et al. Chronic sacral neuromodulation for treatment of neurogenic bladder dysfunction: long-term results with unilateral implants. Urology 2001; 58:887–892.
Wollner J, Krebs J, Pannek J. Sacral neuromodulation in patients with neurogenic lower urinary tract dysfunction. Spinal Cord 2016; 54:137–140.
Shi P, Zhao X, Wang J, et al. Effects of acute sacral neuromodulation on bladder reflex in complete spinal cord injury rats. Neuromodulation 2013; 16:583–589.
Hyun SJ, Lee CH, Kwon JW, et al. Comparative analysis between thoracic spinal cord and sacral neuromodulation in a rat spinal cord injury model: a preliminary report of a rat spinal cord stimulation model. Korean J Spine 2013; 10:14–18.
Lombardi G, Del Popolo G. Clinical outcome of sacral neuromodulation in incomplete spinal cord injured patients suffering from neurogenic lower urinary tract symptoms. Spinal Cord 2009; 47:486–491.
Kessler TM, La Framboise D, Trelle S, et al. Sacral neuromodulation for neurogenic lower urinary tract dysfunction: systematic review and meta-analysis. Eur Urol 2010; 58:865–874.
Lombardi G, Nelli F, Mencarini M, et al. Clinical concomitant benefits on pelvic floor dysfunctions after sacral neuromodulation in patients with incomplete spinal cord injury. Spinal Cord 2011; 49:629–636.
Chen G, Liao L. Sacral neuromodulation for neurogenic bladder and bowel dysfunction with multiple symptoms secondary to spinal cord disease. Spinal Cord 2015; 53:204–208.
Peters KM, Kandagatla P, Killinger KA, et al. Clinical outcomes of sacral neuromodulation in patients with neurologic conditions. Urology 2013; 81:738–743.
Siegel S, Noblett K, Mangel J, et al. Five-year followup results of a prospective, multicenter study of patients with overactive bladder treated with sacral neuromodulation. J Urol 2018; 199:229–236. Long-term follow up.
Siegel S, Noblett K, Mangel J, et al. Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim therapy compared to standard medical therapy at 6-months in individuals with mild symptoms of overactive bladder. Neurourol Urodyn 2015; 34:224–230.
Amarenco G, Ismael SS, Even-Schneider A, et al. Urodynamic effect of acute transcutaneous posterior tibial nerve stimulation in overactive bladder. J Urol 2003; 169:2210–2215.
Gobbi C, Digesu GA, Khullar V, et al. Percutaneous posterior tibial nerve stimulation as an effective treatment of refractory lower urinary tract symptoms in patients with multiple sclerosis: preliminary data from a multicentre, prospective, open label trial. Mult Scler 2011; 17:1514–1519.
Kabay SC, Yucel M, Kabay S. Acute effect of posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with multiple sclerosis: urodynamic study. Urology 2008; 71:641–645.
Kabay S, Kabay SC, Yucel M, et al. The clinical and urodynamic results of a 3-month percutaneous posterior tibial nerve stimulation treatment in patients with multiple sclerosis-related neurogenic bladder dysfunction. Neurourol Urodyn 2009; 28:964–968.
Canbaz Kabay S, Kabay S, Mestan E, et al. Long term sustained therapeutic effects of percutaneous posterior tibial nerve stimulation treatment of neurogenic overactive bladder in multiple sclerosis patients: 12-months results. Neurourol Urodyn 2017; 36:104–110.
Kabay SC, Kabay S, Yucel M, et al. Acute urodynamic effects of percutaneous posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with Parkinson's disease. Neurourol Urodyn 2009; 28:62–67.
Fjorback MV, van Rey FS, van der Pal F, et al. Acute urodynamic effects of posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with MS. Eur Urol 2007; 51:464–470.
Sievert KD, Gleason CA, Junemann KP, et al. Physiologic bladder evacuation with selective sacral root stimulation: sinusoidal signal and organ-specific frequency. Neurourol Urodyn 2002; 21:80–91.
Boger AS, Bhadra N, Gustafson KJ. High frequency sacral root nerve block allows bladder voiding. Neurourol Urodyn 2012; 31:677–682.
Schieferdecker S, Neudorfer C, El Majdoub F, et al. A retrospective case series of high-frequency spinal cord stimulation (HF10-SCS) in neurogenic bladder incontinence. Oper Neurosurg (Hagerstown) 2019; 17:14–20.
Possover M. The sacral LION procedure for recovery of bladder/rectum/sexual functions in paraplegic patients after explantation of a previous Finetech-Brindley controller. J Minim Invasive Gynecol 2009; 16:98–101.
Lemos N, Bichuetti DB, Marques RM, et al. Laparoscopic implantation of neuromodulators for treating urinary dysfunctions and improving locomotion in multiple sclerosis patients. Int Urogynecol J 2015; 26:1871–1873.
van Breda HMK, Martens FMJ, Tromp J, et al. A new implanted posterior tibial nerve stimulator for the treatment of overactive bladder syndrome: 3-month results of a novel therapy at a single center. J Urol 2017; 198:205–210.
Deer T, Pope J, Benyamin R, et al. Prospective, multicenter, randomized, double-blinded, partial crossover study to assess the safety and efficacy of the novel neuromodulation system in the treatment of patients with chronic pain of peripheral nerve origin. Neuromodulation 2016; 19:91–100.